BioAesthetics
BioAesthetics is a Durham, NC-based biomaterials developer founded in 2015 that builds regenerative medical products for healthcare providers and patients, with women's health-focused investors leading its $6.65M in cumulative funding to date.
- Company typePrivate
- Founded2015
- HeadquartersDurham, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioAesthetics does
BioAesthetics is a privately held biomaterials company founded in 2015 and headquartered in Durham, North Carolina. Its stated mission is to advance biomaterials for clinical use, and its website is organized around two end-user constituencies: "Patients" and "Healthcare Providers," indicating a planned medical-product go-to-market in which clinicians serve as the channel to patient consumers. The company operates with a small leadership team (1–10 employees total) consisting of a founder/CEO, a COO, a Medical Director, and a Quality Director — a structure consistent with a preclinical or early-clinical-stage regenerative medicine or combination product developer rather than a commercial-stage enterprise.
The company has raised approximately $6.65 million cumulatively across disclosed rounds since 2017, including a $6.4 million round in October 2020 led by FemHealth Ventures with participation from SOSV (IndieBio), Joyance Partners, Pelican Capital, and several regional angels and biofunds. Non-dilutive capital has come from the National Science Foundation (~$251K in December 2020) and the North Carolina Biotechnology Center (~$3K in August 2020). The composition of the investor syndicate — particularly the lead by a women's health-focused firm and the inclusion of a consumer health investor — strongly implies a women's health application of the biomaterial platform, most plausibly in reconstructive or regenerative use cases, though the company's website is currently a maintenance/coming-soon page and no specific product names, indications, or regulatory milestones are disclosed in the available data.
There is no evidence of commercial revenue, named customers, pricing, or active product distribution. The company should be understood as an early-stage, pre-commercial biomaterials developer whose current value sits in its proprietary platform, regulatory pathway, and clinical/compliance team rather than in recurring sales. Strategic significance will turn on whether the company can convert its scientific platform into a regulatory-cleared product and establish hospital- or specialty-clinic-based reimbursement and distribution.
BioAesthetics firmographics
Firmographics- Name
- BioAesthetics
- Legal name
- BioAesthetics Corporation
- Website
- https://bio-aesthetics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioAesthetics is a Durham, NC-based biomaterials developer founded in 2015 that builds regenerative medical products for healthcare providers and patients, with women's health-focused investors leading its $6.65M in cumulative funding to date.
- Ownership category
- akta.pro rank
BioAesthetics industry classification
Industry- Product category
- Medical Biomaterials
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
- akta.pro secondary industry
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
Keywords
Where BioAesthetics is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Markets served
BioAesthetics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
BioAesthetics product offering
Product offeringCore offering
BioAesthetics develops biomaterial-based medical products intended to transform patient lives through advancements in biomaterials. The company's website serves both Patients and Healthcare Providers audiences, indicating products positioned for clinical adoption by providers while supporting patient awareness. Specific product names and detailed specifications are not disclosed on the current maintenance/coming-soon page.
Product overview
No product or service information available. The source content is a maintenance page indicating that the website is undergoing maintenance, with contact email [email protected] provided for inquiries.
Differentiator
Problem solved
Functional benefit
Companies that use BioAesthetics
Customer profileIdeal customer profiles1 record
BioAesthetics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioAesthetics partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
BioAesthetics competitors and assessment
Company assessmentBroad incumbents
- Organogenesis: Commercial-stage regenerative medicine company with a portfolio of skin and soft-tissue biologic grafts; comparable to BioAesthetics as a regenerative biomaterials business targeting surgical and reconstructive applications.
- Integra LifeSciences: Broad medical device company with a meaningful regenerative tissue and dermal matrix franchise; comparable to BioAesthetics through its regenerative biomaterials offerings for reconstructive surgery.
Direct peers
- Vericel: Develops autologous cell therapies and tissue-based products for cartilage and soft-tissue repair; comparable as a small/mid-cap regenerative tissue company operating in the reconstructive specialty space alongside BioAesthetics.
- MiMedx: Sells dehydrated human amnion/chorion membrane grafts and other tissue allografts used in surgical and reconstructive procedures; directly comparable to BioAesthetics' tissue-based regenerative graft approach.
- MTF Biologics: Tissue bank and biologics manufacturer producing allograft scaffolds for reconstructive, orthopedic, and wound applications; directly comparable as a peer in regenerative tissue-based grafts.
- LifeNet Health: Non-profit tissue banking and regenerative medicine organization producing allograft grafts for reconstructive surgery; comparable to BioAesthetics as a developer of tissue-based regenerative products.
- AlloSource: Allograft tissue bank producing regenerative grafts used in reconstructive and orthopedic surgery; comparable to BioAesthetics as a peer in tissue-engineered allograft-based products.
Emerging players
- Establishment Labs: Breast-focused aesthetics company developing next-generation breast implant and regenerative technologies; comparable to BioAesthetics through its focus on women's breast aesthetics/reconstruction.
- Sientra: Breast implant and reconstruction device company; comparable to BioAesthetics as a participant in the breast reconstruction product ecosystem, though operating in implants rather than regenerative grafts.
- Vivex Biomedical: Specialty regenerative medicine company offering tissue grafts for wound and surgical applications; comparable as a smaller emerging player in tissue-based regenerative products adjacent to BioAesthetics.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
BioAesthetics social profiles
Digital presenceBioAesthetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioAesthetics leadership team
Management profileNumber of profiles
Profiles4 records
BioAesthetics funding detail
Funding detailFunding overview
Funding rounds6 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioAesthetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioAesthetics
What does BioAesthetics do?
BioAesthetics develops biomaterial-based medical products intended to transform patient lives through advancements in biomaterials. The company's website serves both Patients and Healthcare Providers audiences, indicating products positioned for clinical adoption by providers while supporting patient awareness. Specific product names and detailed specifications are not disclosed on the current maintenance/coming-soon page.
Is BioAesthetics a public or private company?
BioAesthetics is a private company. It is classified as venture growth investor backed and is currently operating.
When was BioAesthetics founded?
BioAesthetics was founded in 2015. It employs 1 to 10 people.
Where is BioAesthetics based?
BioAesthetics is headquartered in Durham, United States, in the North America region.
Who are BioAesthetics's main competitors?
Broad incumbents on record are Organogenesis and Integra LifeSciences. Direct peers are Vericel, MiMedx, MTF Biologics, LifeNet Health and AlloSource. Emerging players are Establishment Labs, Sientra and Vivex Biomedical.
Does BioAesthetics have an API?
No public API is recorded for BioAesthetics.
What industry is BioAesthetics in?
BioAesthetics's product category is Medical Biomaterials. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.